Correlation Between SynCore Biotechnology and Universal Microelectronics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Universal Microelectronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Universal Microelectronics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Universal Microelectronics Co, you can compare the effects of market volatilities on SynCore Biotechnology and Universal Microelectronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Universal Microelectronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Universal Microelectronics.

Diversification Opportunities for SynCore Biotechnology and Universal Microelectronics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SynCore and Universal is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Universal Microelectronics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Microelectronics and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Universal Microelectronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Microelectronics has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Universal Microelectronics go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Universal Microelectronics

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the Universal Microelectronics. But the stock apears to be less risky and, when comparing its historical volatility, SynCore Biotechnology Co is 1.12 times less risky than Universal Microelectronics. The stock trades about -0.08 of its potential returns per unit of risk. The Universal Microelectronics Co is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,905  in Universal Microelectronics Co on August 30, 2024 and sell it today you would lose (285.00) from holding Universal Microelectronics Co or give up 9.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Universal Microelectronics Co

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Universal Microelectronics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Universal Microelectronics Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Universal Microelectronics showed solid returns over the last few months and may actually be approaching a breakup point.

SynCore Biotechnology and Universal Microelectronics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Universal Microelectronics

The main advantage of trading using opposite SynCore Biotechnology and Universal Microelectronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Universal Microelectronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Microelectronics will offset losses from the drop in Universal Microelectronics' long position.
The idea behind SynCore Biotechnology Co and Universal Microelectronics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data